Submission for OMB Review; 30-day Comment Request Progress Reports for Center for Global Health's Low and Mid-Income Countries (LMICs) Global Health Collaborations (NCI), 1921-1922 [2015-00393]
Download as PDF
<![CDATA[
Dated: January 6, 2015.
Mary K. Wakefield,
Administrator.
[FR Doc. 2015–00398 Filed 1–13–15; 8:45 am]
BILLING CODE 4165–15–C
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institutes of Health
Submission for OMB Review; 30-day
Comment Request Progress Reports
for Center for Global Health’s Low and
Mid-Income Countries (LMICs) Global
Health Collaborations (NCI)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH), has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
SUMMARY:
VerDate Sep<11>2014
13:56 Jan 13, 2015
Jkt 235001
listed below. This proposed information
collection was previously published in
the Federal Register on July 28, 2014,
Vol. 79, P. 43755 and allowed 60-days
for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Cancer Institute (NCI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
1921
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
DATES: Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed project,
contact: Paul C. Pearlman, Ph.D., Center
for Global Health, National Cancer
Institute, 9609 Medical Center Dr., RM
3W550, Rockville, MD 20850 or call
non-toll-free number 240–276–5354 or
Email your request, including your
address to: paul.pearlman@nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: Progress Reports
for Center for Global Health’s Low and
Mid-Income Countries (LMICs) Global
E:\FR\FM\14JAN1.SGM
14JAN1
EN14JA15.001</GPH>
Federal Register / Vol. 80, No. 9 / Wednesday, January 14, 2015 / Notices
1922
Federal Register / Vol. 80, No. 9 / Wednesday, January 14, 2015 / Notices
Health Collaborations, 0925–NEW,
National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information
Collection: The Center for Global
Health’s (CGH) Low and Mid-Income
Countries (LMICs) Global Health
Collaborations is proposing new
program specific progress report
guidelines. The CGH LMIC Global
Health Collaborations are part of a pilot
initiative and partnership, between the
NCI CGH and the Office of Cancer
Centers (OCC), to promote
collaborations between the NCI
designated Cancer Centers and foreign
institutions from Low and Middle
Income Countries (LMICs). This
collaboration is designed to develop and
implement mutually beneficial global
cancer research programs by increasing
the capability of these countries to
participate and partner in cancer
research. The proposed guidelines
request information about award
performance related to objectives,
accomplishments, barriers and
challenges, collaborators, and findings.
The information is gathered six months
into the award and 12 months after the
award (upon expiry). This information
is needed to monitor the performance of
this special program within NCI, funded
through three Request for Proposals
(RFPs); the first was released April 18,
2013 and CGH expects to release
another in 2014 and the final one in
2015. The respondents are the Principal
Investigators of the awards. The
information will be used to monitor
individual award performance and the
effectiveness of the program as a whole.
Since these projects are funded through
the contract mechanism, the PIs will not
be required to submit interim and final
progress reports like other National
Institutes of Health grantees must.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
83.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
Form name
Principal Investigators .......................
6 Month Report ................................
12 Month Report ..............................
Dated: January 7, 2015.
Karla Bailey,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2015–00393 Filed 1–13–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Announcement of Requirements and
Registration for: ‘‘Innovations in
Measuring and Managing Addiction
Treatment Quality’’ Challenge
mstockstill on DSK4VPTVN1PROD with NOTICES
Authority: 15 U.S.C. 3719.
Award Approving Official: Dr. Nora
Volkow, Director, National Institute on
Drug Abuse (NIDA)
SUMMARY: Through the ‘‘Innovations in
Measuring and Managing Addiction
Treatment Quality’’ Challenge (the
‘‘Challenge’’), the National Institute on
Drug Abuse (NIDA), a component of the
National Institutes of Health (NIH),
challenges the general public to make
concrete advances toward improving the
quality of addiction treatment.
Specifically, through this Challenge,
NIDA hopes to incentivize the
development of innovative concepts for
quality measurement and quality
management systems based on the latest
science of addiction and its treatment
and of quality measurement and
management. These new concepts
VerDate Sep<11>2014
13:56 Jan 13, 2015
Jkt 235001
Number of
respondents
15
15
would be game-changing because they
would go beyond current performance
measurement concepts in that they
would not be limited by the data
commonly available in current provider
and payer data systems. Instead, they
would (a) more directly reflect the
clinical effects that can and should be
expected from high-quality addiction
treatment; (b) capture what clinicians
and provider organizations need to
measure to help them provide highquality addiction treatment; and (c)
provide a solid basis for measuring
clinician and provider performance that
may be used by patients and other
purchasers to select and incent highquality treatment. NIDA believes that
the development of such quality
measures and management systems has
the potential to meaningfully improve
the quality of addiction treatment both
by giving clinicians and providers the
information they need to assess and
improve the quality of the care they
provide and by providing tools patients
and purchasers can use to shop for the
highest quality providers, allowing
market forces to provide another
incentive for improvement.
DATES:
(1) Submission Period begins January
14, 2015, 9:00 a.m., ET
(2) Submission Period ends June 1,
2015, 5:00 p.m., ET
(3) Judging Period June 2, 2015 and July
15, 2015, 2015
(4) Winners Announced September 30,
2015
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Number of
responses
per
respondent
Average
time per
response
(in hours)
1
1
Total annual
burden hours
90/60
4
23
60
FOR FURTHER INFORMATION CONTACT:
Sarah Q. Duffy, Ph.D., Associate
Director for Economics Research,
Division of Epidemiology, Services and
Prevention Research, National Institute
on Drug Abuse, Phone: 301–443–6504
Email duffys@nida.nih.gov.
SUPPLEMENTARY INFORMATION:
Subject of the Challenge
Scientific knowledge about addiction
and its treatment has increased
markedly over the past several years.
We have a better understanding of the
effects of drugs on the brain. We also
have new, more effective treatments. At
the same time, new health care payment
and delivery models are emerging that
may provide opportunities to further
enhance the quality of addiction
treatment.
It has long been recognized that
health care may be improved through
the development and use of quality
measures and management systems
through which they can be collected,
reported, monitored, and improved
[Ref.1]. Quality measures are meant to
reflect aspects of the care provided, or
outcomes achieved that assess the
health care quality. Health care quality
has been defined as ‘‘the degree to
which health care services for
individuals and populations increase
the likelihood of desired outcomes and
are consistent with current professional
knowledge’’ [Ref 2.]. In 2006 the
Institute of Medicine recommended
developing and implementing a quality
E:\FR\FM\14JAN1.SGM
14JAN1
]]>Agencies
[Federal Register Volume 80, Number 9 (Wednesday, January 14, 2015)]
[Notices]
[Pages 1921-1922]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-00393]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-day Comment Request Progress
Reports for Center for Global Health's Low and Mid-Income Countries
(LMICs) Global Health Collaborations (NCI)
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Institutes of Health (NIH), has
submitted to the Office of Management and Budget (OMB) a request for
review and approval of the information collection listed below. This
proposed information collection was previously published in the Federal
Register on July 28, 2014, Vol. 79, P. 43755 and allowed 60-days for
public comment. No public comments were received. The purpose of this
notice is to allow an additional 30 days for public comment. The
National Cancer Institute (NCI), National Institutes of Health, may not
conduct or sponsor, and the respondent is not required to respond to,
an information collection that has been extended, revised, or
implemented on or after October 1, 1995, unless it displays a currently
valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974,
Attention: NIH Desk Officer.
DATES: Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30-days
of the date of this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, or request more information on the
proposed project, contact: Paul C. Pearlman, Ph.D., Center for Global
Health, National Cancer Institute, 9609 Medical Center Dr., RM 3W550,
Rockville, MD 20850 or call non-toll-free number 240-276-5354 or Email
your request, including your address to: paul.pearlman@nih.gov. Formal
requests for additional plans and instruments must be requested in
writing.
Proposed Collection: Progress Reports for Center for Global
Health's Low and Mid-Income Countries (LMICs) Global
[[Page 1922]]
Health Collaborations, 0925-NEW, National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information Collection: The Center for Global
Health's (CGH) Low and Mid-Income Countries (LMICs) Global Health
Collaborations is proposing new program specific progress report
guidelines. The CGH LMIC Global Health Collaborations are part of a
pilot initiative and partnership, between the NCI CGH and the Office of
Cancer Centers (OCC), to promote collaborations between the NCI
designated Cancer Centers and foreign institutions from Low and Middle
Income Countries (LMICs). This collaboration is designed to develop and
implement mutually beneficial global cancer research programs by
increasing the capability of these countries to participate and partner
in cancer research. The proposed guidelines request information about
award performance related to objectives, accomplishments, barriers and
challenges, collaborators, and findings. The information is gathered
six months into the award and 12 months after the award (upon expiry).
This information is needed to monitor the performance of this special
program within NCI, funded through three Request for Proposals (RFPs);
the first was released April 18, 2013 and CGH expects to release
another in 2014 and the final one in 2015. The respondents are the
Principal Investigators of the awards. The information will be used to
monitor individual award performance and the effectiveness of the
program as a whole. Since these projects are funded through the
contract mechanism, the PIs will not be required to submit interim and
final progress reports like other National Institutes of Health
grantees must.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 83.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Type of respondents Form name Number of responses per per response Total annual
respondents respondent (in hours) burden hours
----------------------------------------------------------------------------------------------------------------
Principal Investigators....... 6 Month Report.. 15 1 90/60 23
12 Month Report. 15 1 4 60
----------------------------------------------------------------------------------------------------------------
Dated: January 7, 2015.
Karla Bailey,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2015-00393 Filed 1-13-15; 8:45 am]
BILLING CODE 4140-01-P
